Avenue Therapeutics Inc (NASDAQ:ATXI)

4.21
Delayed Data
As of Jun 11
 -0.15 / -3.44%
Today’s Change
2.85
Today|||52-Week Range
12.34
-29.24%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Avenue Therapeutics Inc have a median target of 9.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +113.78% increase from the last price of 4.21.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Avenue Therapeutics Inc. This rating has held steady since June, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.06
Sales
$0.00
Reporting Date
Aug 19

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually 8.62%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.